Project aims to facilitate early diagnosis and support efforts to stop the Ebola Virus Disease epidemic
Multinational consortium aims to identify novel biomarkers, and therapeutic targets needed for future precis ion medicine approaches
ENTEROME SA, a clinical-stage biopharmaceutical company, and BIOASTER, the French Institute for Technological Research in Infectious Diseases and Microbiology, today announced they have entered into a research collaboration.
BIOASTER receives $885K grant from the Bill & Melinda Gates Foundation to develop Onchocerciasis advanced rapid diagnostic with Mologic Ltd.
Kaleido Biosciences to collaborate with BIOASTER and MetaGenoPolis to investigate the health potential of a novel class of therapies targeting the microbiome. Kaleido Biosciences, a U.S.-based clinical-stage healthcare company,...